1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. PFIZER INC.
26.81 -0.24 (-0.89%)
42.6M
XNYS Volume

XNYS 09 Mar, 2026 4:18 PM (EDT)

Watchlist

Portfolio

Alert

Drug Approval
China approves Pfizer GLP-1 drug ecnoglutide for weight loss, boosting rivalry with Novo and Lilly See details

Pfizer - PFE - stock price prediction, stock price target, analyst ratings from 28 analysts

Pfizer has a share price target of US$ 28, revenue growth forecast of -2.3%, and profit growth estimate of 55.2% for FY26, based on top 28 analyst calls.